Journal of Tropical Pediatrics Advance Access originally published online on August 30, 2006
Journal of Tropical Pediatrics 2006 52(6):411-415; doi:10.1093/tropej/fml038
[Tc]-99m Thyroid Scintigraphy in Congenital Hypothyroidism Screening Program
aDivision of Neonatology, Department of Pediatrics and
bEndocrine & Metabolism Research Center, Isfahan University of Medical Sciences & Health Services, Iran
cIsfahan University of Medical Sciences, Isfahan, Iran
Correspondence: Ramin Iranpour, MD, Assistant Professor of Neonatology, Isfahan Endocrine & Metabolism Research Center, Sedigheh Tahereh Medical Research Complex, Khorram Street, Jomhouri Square, Isfahan 8187698191, Iran. E-mail < iranpour{at}med.mui.ac.ir>.
 |
Abstract |
|---|
The aetiology of congenital hypothyroidism (CH) may be important in determining disease severity, outcome and treatment schedules because athyroid patients need higher treatment doses and close monitoring particularly early in life. The aim of this study was to evaluate thyroid scintigraphy (TS) findings in infants with CH and to determine the relationship of serum TSH and T4 values with thyroid agenesia, in an attempt to identify factors that may detect thyroid agenesia before treatment. Since August 2002 to April 2005, screening program for CH was carried out in the Isfahan University of Medical Sciences and Health Services, Isfahan, Iran. Screening was performed by measuring both the serums T4 and TSH concentration at day 3–7 of birth. Full-term newborns were recalled based on a serum TSH >20 mIU/l or serum T4 < 6.5 µg/dl and premature newborns based on T4 level by weight and TSH level by age. After repeating the laboratory test and clinical evaluation, Tc-99m TS was recommended for all infants with suspected CH before thyroxin replacement therapy. On the basis of Tc-99m TS, the thyroid gland was classified as normal scan, ectopic, goiter and athyrosis. TS results were compared with serum T4 and TSH levels. Of 93 381 newborns screened over a period of nearly 3 years, 262 neonates were found to have CH. The overall incidence of CH was 1 : 357 live births with a female/male ratio (F/M) of 1.4/1. Thyroid scan was performed on 116 (54%) of the infants with CH; of them, 33 cases (28.4%) were athyrotic (F/M = 0.8/1) while seven infants (6%) had ectopic thyroid (F/M = 1.3/1) and 76 cases (65.6%) had a normal thyroid scan (F/M = 1.5/1). Infants with the absence of thyroid in TS had significantly higher TSH value in comparison with those with ectopic or normal TS (116.3 ± 109.64 vs. 108.10 ± 62.92 or 55.35 ± 48.26 mIU/l, respectively, P < 0.0001). Although not statistically different, the mean T4 level was higher in normal TS group than in ectopic and athyrotic groups (8.03 ± 3.48 vs. 6.36 ± 5.57 or 5.04 ± 3 µg/dl, respectively, P = 0.09). We conclude that Tc-99m TS is a useful diagnostic tool for the initial investigation of suspected CH and considering the correlation of TS results with blood TSH levels, proper management and close monitoring of hypothyroid infants with severe hormonal alterations is necessary for the detection of thyroid agenesia.
Key Words: congenital hypothyroidism • Tc-99m thyroid scintigraphy • thyroid agenesia • screening